Plasmapheresis - Open Access .click

Results 131 to 140 of about 44,809 (280)

Further evidence for plasmapheresis [PDF]

, 1980
Robert G. Hylland
openalex +1 more source

Present and Future of Central Disorders of Hypersomnolence

Journal of Sleep Research, Volume 34, Issue 5, October 2025.
ABSTRACT Central disorders of hypersomnolence (CDH) are rare neurological conditions lumped by excessive daytime sleepiness (EDS) as primary complaint mostly arising at young age, including narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), idiopathic hypersomnia (IH), and Kleine‐Levin syndrome (KLS). Advances in clinical and translational research have
Francesco Biscarini +4 more
wiley +1 more source

Features of surgical treatment of hypertriglyceride–induced acute pancreatitis

Український журнал клінічної хірургії
Objective. To evaluate the effectiveness of surgical treatment of patients with hypertriglyceride–induced acute pancreatitis using plasmapheresis and prioritizing minimally invasive surgical interventions. Materials and methods.
I. M. Shevchuk +4 more
doaj +1 more source

Triple Regimen with Rituximab, Plasmapheresis and Intravenous Immunoglobulin in the Treatment of Dialysis Dependent Acute Humoral-Mediated Rejection in Kidney Grafts [PDF]

, 2006
Introduction: The clinical importance of humoral-mediated acute rejection has been progressively recognised. Early recognition and treatment with plasmapheresis and intravenous immunoglobulin have recently improved short term prognosis.
Barber, E +12 more
core

SARS‐CoV‐2 convalescent plasma for the controlled clinical trial “COVIC‐19”: Experience from collection of very high‐titer plasma from superimmunized individuals

Transfusion, Volume 65, Issue 10, Page 1888-1902, October 2025.
Abstract Background COVID‐19 convalescent plasma (CCP) is a treatment option for COVID‐19. Understanding of donor and product characteristics is important for optimization of CCP therapy. We report the experience of collection of very high‐titer CCP for the trial “A randomized open‐label trial of early, very high‐titer convalescent plasma therapy in ...
Simone Hoffmann +17 more
wiley +1 more source

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis

Annals of Intensive Care
Background Plasmapheresis is widely used for severe hypertriglyceridemia-associated acute pancreatitis (HTG-AP) to remove excessive triglycerides from plasma. This study aimed to evaluate whether plasmapheresis could improve the duration of organ failure
Lanting Wang +16 more
doaj +1 more source

Plasmapheresis in Lupus [PDF]